These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18925940)

  • 21. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation.
    Duncan SR; Scott S; Duncan CJ
    J Med Genet; 2005 Mar; 42(3):205-8. PubMed ID: 15744032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.
    Stephens JC; Reich DE; Goldstein DB; Shin HD; Smith MW; Carrington M; Winkler C; Huttley GA; Allikmets R; Schriml L; Gerrard B; Malasky M; Ramos MD; Morlot S; Tzetis M; Oddoux C; di Giovine FS; Nasioulas G; Chandler D; Aseev M; Hanson M; Kalaydjieva L; Glavac D; Gasparini P; Kanavakis E; Claustres M; Kambouris M; Ostrer H; Duff G; Baranov V; Sibul H; Metspalu A; Goldman D; Martin N; Duffy D; Schmidtke J; Estivill X; O'Brien SJ; Dean M
    Am J Hum Genet; 1998 Jun; 62(6):1507-15. PubMed ID: 9585595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of the CCR5 gene 32-base pair deletion in Israeli ethnic groups.
    Kantor R; Gershoni JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):81-4. PubMed ID: 9928734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of CCR5 gene 32-basepair deletion in Croatian normal population.
    Ristić S; Starcević Cizmarević N; Brajenović-Milić B; Crnić-Martinović M; Kapović M
    Croat Med J; 2005 Aug; 46(4):693-4. PubMed ID: 16100775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
    Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
    Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis.
    Al-Jaberi SA; Ben-Salem S; Messedi M; Ayadi F; Al-Gazali L; Ali BR
    Gene; 2013 Oct; 529(1):113-8. PubMed ID: 23933274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine receptor V Δ32 deletion in multiple sclerosis patients in Csongrád County in Hungary and the North-Bácska region in Serbia.
    Török N; Molnár K; Füvesi J; Karácsony M; Zsiros V; Fejes-Szabó A; Fiatal S; Ádány R; Somogyvári F; Stojiljković O; Vécsei L; Bencsik K
    Hum Immunol; 2015 Jan; 76(1):59-64. PubMed ID: 25500253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Prahalad S
    Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is spatial distribution of the HIV-1-resistant CCR5Delta32 allele formed by ecological factors?
    Balanovsky O; Pocheshkhova E; Pshenichnov A; Solovieva D; Kuznetsova M; Voronko O; Churnosov M; Tegako O; Atramentova L; Lavryashina M; Evseeva I; Borinska S; Boldyreva M; Dubova N; Balanovska E
    J Physiol Anthropol Appl Human Sci; 2005 Jul; 24(4):375-82. PubMed ID: 16079584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.
    Klitz W; Brautbar C; Schito AM; Barcellos LF; Oksenberg JR
    Hum Immunol; 2001 May; 62(5):530-8. PubMed ID: 11334678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy.
    Panzer U; Schneider A; Steinmetz OM; Wenzel U; Barth P; Reinking R; Becker JU; Harendza S; Zahner G; Fischereder M; Krämer BK; Schlöndorff D; Ostendorf T; Floege J; Helmchen U; Stahl RA
    Kidney Int; 2005 Jan; 67(1):75-81. PubMed ID: 15610230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Ground truth" for selection on CCR5-Delta32.
    Hedrick PW; Verrelli BC
    Trends Genet; 2006 Jun; 22(6):293-6. PubMed ID: 16678299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of the CCR5-Delta32 polymorphism in the Maltese population at birth.
    Vidal C; Xuereb-Anastasi A
    Int J Immunogenet; 2009 Oct; 36(5):301-4. PubMed ID: 19744036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
    van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H
    J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of the CCR5-delta32 deletion in Southwest Germany.
    Hütter G; Blüthgen C; Elvers-Hornung S; Klüter H; Bugert P
    Anthropol Anz; 2015; 72(3):303-9. PubMed ID: 25807520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.